Trial · NCT02617446
Results by group228
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 228
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in E/Ea Ratio | Istaroxime 0.5 µg/kg/Min | -4.55 | 95% Confidence Interval -6.05 to -3.04 | Unitless ratio | |
| Change in E/Ea Ratio | Placebo Cohort I | -1.55 | 95% Confidence Interval -3.77 to 0.67 | Unitless ratio | |
| Change in E/Ea Ratio | Istaroxime 1.0 µg/kg/Min | -3.16 | 95% Confidence Interval -4.09 to -2.24 | Unitless ratio | |
| Change in E/Ea Ratio | Placebo Cohort II | -1.08 | 95% Confidence Interval -2.30 to 0.13 | Unitless ratio | |
| Change in LVEF | Istaroxime 0.5 µg/kg/Min | 3.026 | 95% Confidence Interval 1.850 to 4.203 | % of blood leaving the heart | |
| Change in LVEF | Placebo Cohort I | 1.263 | 95% Confidence Interval -0.401 to 2.927 | % of blood leaving the heart | |
| Change in LVEF | Istaroxime 1.0 µg/kg/Min | 3.818 | 95% Confidence Interval 2.362 to 5.275 | % of blood leaving the heart | |
| Change in LVEF | Placebo Cohort II | 2.833 | 95% Confidence Interval 0.861 to 4.805 | % of blood leaving the heart | |
| Change in SVI | Istaroxime 0.5 µg/kg/Min | 5.334 | 95% Confidence Interval 3.371 to 7.296 | mL/m² | |
| Change in SVI | Placebo Cohort I | 1.649 | 95% Confidence Interval -1.126 to 4.425 | mL/m² | |
| Change in SVI | Istaroxime 1.0 µg/kg/Min | 5.488 | 95% Confidence Interval 3.882 to 7.094 | mL/m² | |
| Change in SVI | Placebo Cohort II | 3.178 | 95% Confidence Interval 1.030 to 5.327 | mL/m² | |
| Change in E/A Ratio | Istaroxime 0.5 µg/kg/Min | -0.643 | 95% Confidence Interval -1.091 to -0.197 | Unitless ratio | |
| Change in E/A Ratio | Placebo Cohort I | 0.133 | 95% Confidence Interval -0.463 to 0.729 | Unitless ratio | |
| Change in E/A Ratio | Istaroxime 1.0 µg/kg/Min | -0.654 | 95% Confidence Interval -1.093 to -0.216 | Unitless ratio | |
| Change in E/A Ratio | Placebo Cohort II | 0.175 | 95% Confidence Interval -0.419 to 0.769 | Unitless ratio | |
| Change in LV End Systolic Volume | Istaroxime 0.5 µg/kg/Min | -7.105 | 95% Confidence Interval -10.933 to -3.277 | mL | |
| Change in LV End Systolic Volume | Placebo Cohort I | -1.736 | 95% Confidence Interval -7.150 to 3.677 | mL | |
| Change in LV End Systolic Volume | Istaroxime 1.0 µg/kg/Min | -11.39 | 95% Confidence Interval -17.438 to -5.350 | mL | |
| Change in LV End Systolic Volume | Placebo Cohort II | -11.83 | 95% Confidence Interval -20.017 to -3.649 | mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02617446/results